×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
Yahoo Finance
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript May 9, 2024 Sangamo Therapeutics, Inc. isn't one of the 30 most...
4 days ago
Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know
markets.businessinsider.com
In the preceding three months, 4 analysts have released ratings for Sangamo Therapeutics (NASDAQ:SGMO), presenting a wide array of...
1 day ago
This Just In: Analysts Are Boosting Their Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Outlook for This Year
Simply Wall Street
Shareholders in Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) may be thrilled to learn that the analysts have just...
2 days ago
HC Wainwright Weighs in on Sangamo Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:SGMO)
MarketBeat
Sangamo Therapeutics, Inc. (NASDAQ:SGMO - Free Report) - HC Wainwright issued their Q1 2025 earnings estimates for Sangamo Therapeutics in a...
6 hours ago
Sangamo Therapeutics Shares Drop 15% After $24M Offering Prices
MarketWatch
By Chris Wack Sangamo Therapeutics shares were down 14% to 83 cents after the company entered a securities purchase agreement with...
1 month ago
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
Sangamo (SGMO) delivered earnings and revenue surprises of -22.73% and 94.35%, respectively, for the quarter ended March 2024.
6 days ago
US$3.50 - That's What Analysts Think Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Is Worth After These Results
Yahoo Finance
The analysts might have been a bit too bullish on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ), given that the company...
4 days ago
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
Business Wire
Showcased 20 presentations at the 27th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting demonstrating progression of...
1 week ago
Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
Business Wire
RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company...
2 weeks ago
Sangamo Therapeutics' (SGMO) "Buy" Rating Reiterated at HC Wainwright
MarketBeat
HC Wainwright reissued a "buy" rating and set a $5.00 price objective on shares of Sangamo Therapeutics in a report on Wednesday.
1 day ago